Literature DB >> 20739752

Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis.

Xingshen Sun1, Hongshu Sui, John T Fisher, Ziying Yan, Xiaoming Liu, Hyung-Ju Cho, Nam Soo Joo, Yulong Zhang, Weihong Zhou, Yaling Yi, Joann M Kinyon, Diana C Lei-Butters, Michelle A Griffin, Paul Naumann, Meihui Luo, Jill Ascher, Kai Wang, Timothy Frana, Jeffrey J Wine, David K Meyerholz, John F Engelhardt.   

Abstract

Cystic fibrosis (CF) is a recessive disease that affects multiple organs. It is caused by mutations in CFTR. Animal modeling of this disease has been challenging, with species- and strain-specific differences in organ biology and CFTR function influencing the emergence of disease pathology. Here, we report the phenotype of a CFTR-knockout ferret model of CF. Neonatal CFTR-knockout ferrets demonstrated many of the characteristics of human CF disease, including defective airway chloride transport and submucosal gland fluid secretion; variably penetrant meconium ileus (MI); pancreatic, liver, and vas deferens disease; and a predisposition to lung infection in the early postnatal period. Severe malabsorption by the gastrointestinal (GI) tract was the primary cause of death in CFTR-knockout kits that escaped MI. Elevated liver function tests in CFTR-knockout kits were corrected by oral administration of ursodeoxycholic acid, and the addition of an oral proton-pump inhibitor improved weight gain and survival. To overcome the limitations imposed by the severe intestinal phenotype, we cloned 4 gut-corrected transgenic CFTR-knockout kits that expressed ferret CFTR specifically in the intestine. One clone passed feces normally and demonstrated no detectable ferret CFTR expression in the lung or liver. The animals described in this study are likely to be useful tools for dissecting CF disease pathogenesis and developing treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739752      PMCID: PMC2929732          DOI: 10.1172/JCI43052

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Submucosal glands and airway defense.

Authors:  Jeffrey J Wine; Nam Soo Joo
Journal:  Proc Am Thorac Soc       Date:  2004

2.  Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis.

Authors:  H Scher; W P Bishop; P B McCray
Journal:  Ann Pharmacother       Date:  1997-09       Impact factor: 3.154

3.  Quantitation of the secretory cells of the ferret tracheobronchial tree.

Authors:  N P Robinson; L Venning; H Kyle; J G Widdicombe
Journal:  J Anat       Date:  1986-04       Impact factor: 2.610

4.  Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions.

Authors:  E H Oppenheimer; J R Esterly
Journal:  Arch Pathol       Date:  1973-09

5.  In vivo analysis of fluid transport in cystic fibrosis airway epithelia of bronchial xenografts.

Authors:  Y Zhang; J Yankaskas; J Wilson; J F Engelhardt
Journal:  Am J Physiol       Date:  1996-05

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Lysozyme secretion by submucosal glands protects the airway from bacterial infection.

Authors:  Rana Dajani; Yulong Zhang; Peter J Taft; Sue M Travis; Timothy D Starner; Ansgar Olsen; Joseph Zabner; Michael J Welsh; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-03       Impact factor: 6.914

8.  Cloned ferrets produced by somatic cell nuclear transfer.

Authors:  Ziyi Li; Xingshen Sun; Juan Chen; Xiaoming Liu; Samantha M Wisely; Qi Zhou; Jean-Paul Renard; Gregory H Leno; John F Engelhardt
Journal:  Dev Biol       Date:  2006-04-03       Impact factor: 3.582

9.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

10.  N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic.

Authors:  Rina Glozman; Tsukasa Okiyoneda; Cory M Mulvihill; James M Rini; Herve Barriere; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

View more
  177 in total

1.  Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.

Authors:  Kiranya E Tipirneni; Do-Yeon Cho; Daniel F Skinner; Shaoyan Zhang; Calvin Mackey; Dong-Jin Lim; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2017-08-03       Impact factor: 3.325

Review 2.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

Review 3.  Cystic fibrosis: an inherited disease affecting mucin-producing organs.

Authors:  Camille Ehre; Caroline Ridley; David J Thornton
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

Review 4.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

Review 5.  Genetic therapies for cystic fibrosis lung disease.

Authors:  Patrick L Sinn; Reshma M Anthony; Paul B McCray
Journal:  Hum Mol Genet       Date:  2011-03-21       Impact factor: 6.150

6.  Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report.

Authors:  Bonnie W Ramsey; Susan Banks-Schlegel; Frank J Accurso; Richard C Boucher; Garry R Cutting; John F Engelhardt; William B Guggino; Christopher L Karp; Michael R Knowles; Jay K Kolls; John J LiPuma; Susan Lynch; Paul B McCray; Ronald C Rubenstein; Pradeep K Singh; Eric Sorscher; Michael Welsh
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

7.  Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.

Authors:  Zhiwei Cai; Timea Palmai-Pallag; Pissared Khuituan; Michael J Mutolo; Clément Boinot; Beihui Liu; Toby S Scott-Ward; Isabelle Callebaut; Ann Harris; David N Sheppard
Journal:  J Physiol       Date:  2015-04-09       Impact factor: 5.182

Review 8.  Animal models for cystic fibrosis liver disease (CFLD).

Authors:  Romina Fiorotto; Mariangela Amenduni; Valeria Mariotti; Massimiliano Cadamuro; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-07-30       Impact factor: 5.187

9.  A ferret model of COPD-related chronic bronchitis.

Authors:  S Vamsee Raju; Hyunki Kim; Stephen A Byzek; Li Ping Tang; John E Trombley; Patricia Jackson; Lawrence Rasmussen; J Michael Wells; Emily Falk Libby; Erik Dohm; Lindy Winter; Sharon L Samuel; Kurt R Zinn; J Edwin Blalock; Trenton R Schoeb; Mark T Dransfield; Steven M Rowe
Journal:  JCI Insight       Date:  2016-09-22

10.  Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Authors:  Ziying Yan; Xingshen Sun; Zehua Feng; Guiying Li; John T Fisher; Zoe A Stewart; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2015-04-20       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.